ARTICLE | Distillery Therapeutics
Targeting proBDNF signaling to treat SLE
March 4, 2022 7:46 PM UTC
DISEASE CATEGORY: Autoimmune disease
INDICATION: Lupus...
BCIQ Company Profiles
Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
DISEASE CATEGORY: Autoimmune disease
INDICATION: Lupus...
BCIQ Company Profiles
BCIQ Company Profiles